Endocrinology Medical News

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Effect of the site of measurement of waist circumference on the prevalence of the metabolic syndrome
The American Journal of Cardiology, 06/23/09

Mason C et al. – Prevalence of the metabolic syndrome (MS) is modestly influenced by the anatomic site of waist circumference (WC) measurement. Efforts should be made to standardize the protocol for measurement of WC given its potential to influence research findings and clinical decision-making.

Methods

Study of whether WC is differentially associated with cardiometabolic risk factors based on its anatomic measurement site
Quantification of the impact of measurement site on prevalence of MS
Sample of 520 community-dwelling adults (208 men, 312 women)
Measurement of WC at 4 common sites: superior border of iliac crest, midpoint between iliac crest and lowest rib, umbilicus, and minimal waist
Measurement of blood pressure at rest
Analysis of fasting blood samples for concentrations of high-density lipoprotein cholesterol, triglycerides, and glucose
MS diagnosed by criteria of American Heart Association/National Heart, Lung, and Blood Institute

Results

Similar overall patterns of association between WC and cardiometabolic risk factors across anatomic locations of measurement
In men, same prevalence of MS for WC measured at iliac crest, midpoint, umbilicus (21.2%) but lower (18.3%) using minimal waist
In women, MS prevalences: 15.1%, 14.4%, 14.1%, and 13.1% using umbilicus, iliac crest, midpoint, and minimal waist, respectively

<< Previous
Rosiglitazone enhances glucose uptake in glomerular podocytes...

Next >>
Rosiglitazone evaluated for cardiovascular outcomes in oral agent...